About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

IL-38 Evaluation as a Biomarker in Pediatric Asthma

NCT05366491·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Cairo University

Age

6–14

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

patients fulfilled the criteria of the Global Initiative for Asthma (GINA)
Age group:6-14 years

You may not be if

Malignancy
Chronic inflammatory diseases

The record

StatusCompleted

PhaseNo phase

Taking part103

StartedAug 2020

UpdatedMay 12, 2022

Conditions

Bronchial Asthma

Where1

Asmaa Kamal
Cairo, Egypt

Clareo Health | IL-38 Evaluation as a Biomarker in Pediatric Asthma